Oil prices have picked up as supply routes face higher risk, and central banks are signalling that interest rates may stay elevated for longer. That mix keeps pressure on growth, so investors are hunting for companies that can grow from their own steam. Fast growing stocks with high insider ownership can be especially interesting. This article highlights three such stocks that may be worth a closer look.

The stocks covered below are just a starting sample, and the full screen surfaced 167 more companies with equally compelling insider backed growth stories that are not included here. To go deeper into this idea, head straight into the Fast Growing Stocks With High Insider Ownership screener to identify, filter and analyze the highest conviction plays that fit your approach.

Precigen (PGEN)

Overview: Precigen is a clinical stage biopharmaceutical company that develops gene and cell therapies for cancer, autoimmune conditions and infectious diseases, anchored by its AdenoVerse and UltraCAR T technology platforms and its first commercial product PAPZIMEOS for recurrent respiratory papillomatosis. The focus is on patients with high unmet medical need, where differentiated therapies and regulatory exclusivity can matter most.

Operations: Precigen generates essentially all of its roughly US$86 million in revenue from its Biotechnology startups segment, with almost all sales coming from the United States at about US$85 million.

Market Cap: US$2.47 billion

Investors watching high growth, insider backed biotech stories may find Precigen interesting because PAPZIMEOS already has seven year FDA exclusivity for adult recurrent respiratory papillomatosis and has reached more than 200 treated patients, with Q2 2026 revenue of about US$53 million from this therapy and net profitability in the quarter. At the same time, in house manufacturing and broad payer coverage could help support margins. The flip side is meaningful risk from a rich valuation, past shareholder dilution, recent insider selling and reliance on a single lead product for now, so the story rewards careful further research before deciding how it fits in your portfolio.

Precigen’s PAPZIMEOS story is already unusual, with FDA exclusivity, in house manufacturing and net profitability in Q2 2026. Yet the real twist shows up in the 1 key reward and 3 important warning signs (1 is major!)

Build your own insider backed growth shortlist

Precigen and the two other stocks in this article all came from the same screener, which means you can set up your own filter set just as easily. Use our flexible Screener to mix metrics like growth, valuation and balance sheet strength, or lean on the foundations of our curated Investing Ideas.

Chime Financial (CHYM)

Overview: Chime Financial is a San Francisco based fintech that offers app based banking for everyday spending and saving, with products like checking style spending accounts, debit cards, credit builder tools, short term liquidity features and a growing set of savings, investing and workplace benefits for consumers in the United States and internationally.

Operations: Chime Financial generates all of its roughly US$2.46b in revenue from data processing services, with all reported revenue coming from the United States.

Market Cap: US$11.83b

Chime Financial sits at the center of app based banking, with around 9.1 million active members and a proprietary processing engine that management expects to push gross margin close to 90%. Q2 2026 brought a second straight quarter of GAAP profitability, US$669.77 million in revenue and US$81.31 million in net income, alongside raised full year guidance and fresh momentum in Chime Prime and Chime Invest. At the same time, the stock carries risks that matter, including high CEO pay, reliance on higher risk external funding rather than customer deposits and sensitivity to interchange and credit losses. For investors who want to understand why analysts have become more upbeat, the recent earnings and product shifts deserve a closer look.

Chime Financial’s revenue engine and fresh GAAP profitability suggest the story may be shifting from promise to proof. Get the full context through the analysis report for Chime Financial and see what might be hiding behind those margins and funding choices.

Clear Secure (YOU)

Overview: Clear Secure runs the CLEAR identity platform that speeds up ID checks in airports and other venues, mainly through its CLEAR Plus subscription, mobile app and digital ID tools. The company also offers services like TSA PreCheck enrollment, virtual queuing and CLEAR1 for businesses that want quicker, fraud resistant customer verification.

Market Cap: US$7.17 billion

Clear Secure catches the eye because it sits at the intersection of rising travel volumes and growing demand for fast, secure identity checks. Revenue in Q2 2026 was US$277.76 million with US$50.05 million in net income, free cash flow is guided to at least US$480 million for 2026, and return on equity is 90.6%. At the same time, profit margins have compressed from 21.2% to 14.8% and there has been significant insider selling, so the story involves risks as well as opportunities. For investors who believe that airport automation, digital ID partnerships with groups such as Samsung and Expedia, and expanding B2B use cases are important factors, Clear Secure may merit closer attention.

Clear Secure’s high return on equity and strong free cash flow guidance sit next to margin pressure and insider selling that many investors may be glossing over. See how those threads tie together in the 2 key rewards and 2 important warning signs

Seeking Fresh Alternatives Before They Fly

New themes can start to break out before most investors even notice. Momentum can shift quickly, and early data points can fade from view. Review these fresh stock ideas and consider how they might fit your approach.

• Spot companies quietly building financial strength before the crowd catches on by reviewing the curated list of solid balance sheet and fundamentals (49 results) while that quality is still under the radar.
• Look for potential momentum in income payers instead of watching yields slip away by focusing on the hand picked group in the 8 dividend fortresses while it may still be relevant.
• Track emerging robotics themes before they become widely followed by checking the tightly filtered set inside the 36 robotics and automation stocks while these stories are still outside mainstream attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.